102 On the flip side, several groups are advocating with the incorporation of novel markers, such as a advanced karyotype55 or epigenetic subsets, 27,28 into scientific practice. Every one of these novel prognostic and/or predictive products will must be validated in cohorts of sufferers handled with targeted brokers.Richter transformation stays an